Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ras”

843 pharma patents match "ras" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 843
Index total 30,257
Page 21 / 36

Quick answer

This filtered view shows 843 pharmaceutical patents matching "ras" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

843 results for “ras” · 30,257 patents in full index Clear search

  1. US 8916566

    Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders

    Takeda Pharmaceutical Company Limited · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted

  2. US 8911743

    Haemophilus parasuis polypeptides and methods of use

    Regents of the University of Minnesota · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  3. US 8912142

    Method of regulating proliferation and differentiation of keratinocyes

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  4. US 8912326

    Process of making gyrase and topoisomerase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  5. US 8883841

    Oncogenic ras-specific cytotoxic compound and methods of use thereof

    The Board of Regents of the University of Texas System · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted

  6. US 8883448

    Mutated ras peptides for generation of CD8+ cytotoxic T lymphocytes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted

  7. EP 2791134

    CHEMISCHE VERBINDUNG ALS ZWISCHENPRODUKT ZUR HERSTELLUNG EINES CATECHOL-O-METHYLTRANSFERASE-INHIBITORS

    BIAL PORTELA & Cª S A [PT] · Granted Oct 22, 2014 · Expires Oct 17, 2034

    granted

  8. US 8865230

    Compositions and methods for treating parasitic infections

    TYRATECH, INC. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  9. US 8865686

    Tetracycline compounds as tyrosyl-DNA phosphodiesterase I inhibitors

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  10. US 8846713

    Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitors

    Takeda Pharmaceutical Company Limited · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  11. US 8841350

    Method for inducing UDP-glucuronosyltransferase activity using pterostilbene

    The Regents of the University of California · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

  12. US 8828722

    Isolated populations of renal stem cells and methods of isolating and using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  13. US 8828356

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  14. US 8821943

    Methods and compositions for targeted delivery of therapeutic agents

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  15. US 8809310

    Use of rasagiline for the treatment of multiple system atrophy

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  16. US 8802854

    Crystalline forms of Prasugrel salts

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted

  17. US 8796438

    Nucleic acids encoding inactive variants of human telomerase

    The Regents of the University of Colorado · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  18. US 8785373

    Agents capable of downregulating an MSF-A-dependent HIF-1alpha and use thereof in cancer treatment

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  19. US 8778671

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  20. US 8772247

    Anti-parasitic compounds

    The Regents of the University of California · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted

  21. US 8771665

    Inhibitors of hepatitis C virus polymerase

    COCRYSTAL, DISCOVERY, INC. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted

  22. US 8754080

    Pyrimidine substituted purine compounds as kinase (S) inhibitors

    VERASTEM, INC. · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  23. US 8741315

    Methods of treating tumors in immune-privileged sites

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Jun 3, 2014 · Expires May 29, 2034

    granted

  24. US 8735075

    Cancer screening by detection of ultrastructural and molecular markers

    Northwestern University · Granted May 27, 2014 · Expires May 22, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.